Thyroid hormone receptors promote metastasis of human hepatoma cells via regulation of TRAIL

H. C. Chi, S. L. Chen, C. J. Liao, C. J. Liao, M. M. Tsai, Y. H. Lin, Y. H. Huang, C. T. Yeh, S. M. Wu, Y. H. Tseng, C. Y. Chen, C. Y. Tsai, I. H. Chung, W. J. Chen, K. H. Lin

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Although accumulating evidence has confirmed the important roles of thyroid hormone (T 3) and its receptors (TRs) in tumor progression, the specific functions of TRs in carcinogenesis remain unclear. In the present study, tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) was directly upregulated by T 3 in TR-overexpressing hepatoma cell lines. TRAIL is an apoptotic inducer, but it can nonetheless trigger non-apoptotic signals favoring tumorigenesis in apoptosis-resistant cancer cells. We found that TR-overexpressing hepatoma cells treated with T 3 were apoptosis resistant, even when TRAIL was upregulated. This apoptotic resistance may be attributable to simultaneous upregulation of Bcl-xL by T 3, because (1) knockdown of T 3-induced Bcl-xL expression suppressed T 3-mediated protection against apoptosis, and (2) overexpression of Bcl-xL further protected hepatoma cells from TRAIL-induced apoptotic death, consequently leading to TRAIL-promoted metastasis of hepatoma cells. Moreover, T 3-enhanced metastasis in vivo was repressed by the treatment of TRAIL-blocking antibody. Notably, TRAIL was highly expressed in a subset of hepatocellular carcinoma (HCC) patients, and this high-level expression was significantly correlated with that of TRs in these HCC tissues. Together, our findings provide evidence for the existence of a novel mechanistic link between increased TR and TRAIL levels in HCC. Thus, TRs induce TRAIL expression, and TRAIL thus synthesized acts in concert with simultaneously synthesized Bcl-xL to promote metastasis, but not apoptosis.

Original languageEnglish
Pages (from-to)1802-1814
Number of pages13
JournalCell Death and Differentiation
Volume19
Issue number11
DOIs
Publication statusPublished - Nov 2012
Externally publishedYes

Fingerprint

TNF-Related Apoptosis-Inducing Ligand
Thyroid Hormone Receptors
Hepatocellular Carcinoma
Neoplasm Metastasis
Apoptosis
Carcinogenesis
Blocking Antibodies
Thyroid Hormones
Neoplasms
Up-Regulation
Tumor Necrosis Factor-alpha
Ligands

Keywords

  • apoptosis
  • metastasis
  • thyroid hormone receptor
  • TRAIL

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology

Cite this

Chi, H. C., Chen, S. L., Liao, C. J., Liao, C. J., Tsai, M. M., Lin, Y. H., ... Lin, K. H. (2012). Thyroid hormone receptors promote metastasis of human hepatoma cells via regulation of TRAIL. Cell Death and Differentiation, 19(11), 1802-1814. https://doi.org/10.1038/cdd.2012.58

Thyroid hormone receptors promote metastasis of human hepatoma cells via regulation of TRAIL. / Chi, H. C.; Chen, S. L.; Liao, C. J.; Liao, C. J.; Tsai, M. M.; Lin, Y. H.; Huang, Y. H.; Yeh, C. T.; Wu, S. M.; Tseng, Y. H.; Chen, C. Y.; Tsai, C. Y.; Chung, I. H.; Chen, W. J.; Lin, K. H.

In: Cell Death and Differentiation, Vol. 19, No. 11, 11.2012, p. 1802-1814.

Research output: Contribution to journalArticle

Chi, HC, Chen, SL, Liao, CJ, Liao, CJ, Tsai, MM, Lin, YH, Huang, YH, Yeh, CT, Wu, SM, Tseng, YH, Chen, CY, Tsai, CY, Chung, IH, Chen, WJ & Lin, KH 2012, 'Thyroid hormone receptors promote metastasis of human hepatoma cells via regulation of TRAIL', Cell Death and Differentiation, vol. 19, no. 11, pp. 1802-1814. https://doi.org/10.1038/cdd.2012.58
Chi, H. C. ; Chen, S. L. ; Liao, C. J. ; Liao, C. J. ; Tsai, M. M. ; Lin, Y. H. ; Huang, Y. H. ; Yeh, C. T. ; Wu, S. M. ; Tseng, Y. H. ; Chen, C. Y. ; Tsai, C. Y. ; Chung, I. H. ; Chen, W. J. ; Lin, K. H. / Thyroid hormone receptors promote metastasis of human hepatoma cells via regulation of TRAIL. In: Cell Death and Differentiation. 2012 ; Vol. 19, No. 11. pp. 1802-1814.
@article{ccd2e2ba8d4f4c6caace7bf8c77cb5f0,
title = "Thyroid hormone receptors promote metastasis of human hepatoma cells via regulation of TRAIL",
abstract = "Although accumulating evidence has confirmed the important roles of thyroid hormone (T 3) and its receptors (TRs) in tumor progression, the specific functions of TRs in carcinogenesis remain unclear. In the present study, tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) was directly upregulated by T 3 in TR-overexpressing hepatoma cell lines. TRAIL is an apoptotic inducer, but it can nonetheless trigger non-apoptotic signals favoring tumorigenesis in apoptosis-resistant cancer cells. We found that TR-overexpressing hepatoma cells treated with T 3 were apoptosis resistant, even when TRAIL was upregulated. This apoptotic resistance may be attributable to simultaneous upregulation of Bcl-xL by T 3, because (1) knockdown of T 3-induced Bcl-xL expression suppressed T 3-mediated protection against apoptosis, and (2) overexpression of Bcl-xL further protected hepatoma cells from TRAIL-induced apoptotic death, consequently leading to TRAIL-promoted metastasis of hepatoma cells. Moreover, T 3-enhanced metastasis in vivo was repressed by the treatment of TRAIL-blocking antibody. Notably, TRAIL was highly expressed in a subset of hepatocellular carcinoma (HCC) patients, and this high-level expression was significantly correlated with that of TRs in these HCC tissues. Together, our findings provide evidence for the existence of a novel mechanistic link between increased TR and TRAIL levels in HCC. Thus, TRs induce TRAIL expression, and TRAIL thus synthesized acts in concert with simultaneously synthesized Bcl-xL to promote metastasis, but not apoptosis.",
keywords = "apoptosis, metastasis, thyroid hormone receptor, TRAIL",
author = "Chi, {H. C.} and Chen, {S. L.} and Liao, {C. J.} and Liao, {C. J.} and Tsai, {M. M.} and Lin, {Y. H.} and Huang, {Y. H.} and Yeh, {C. T.} and Wu, {S. M.} and Tseng, {Y. H.} and Chen, {C. Y.} and Tsai, {C. Y.} and Chung, {I. H.} and Chen, {W. J.} and Lin, {K. H.}",
year = "2012",
month = "11",
doi = "10.1038/cdd.2012.58",
language = "English",
volume = "19",
pages = "1802--1814",
journal = "Cell Death and Differentiation",
issn = "1350-9047",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Thyroid hormone receptors promote metastasis of human hepatoma cells via regulation of TRAIL

AU - Chi, H. C.

AU - Chen, S. L.

AU - Liao, C. J.

AU - Liao, C. J.

AU - Tsai, M. M.

AU - Lin, Y. H.

AU - Huang, Y. H.

AU - Yeh, C. T.

AU - Wu, S. M.

AU - Tseng, Y. H.

AU - Chen, C. Y.

AU - Tsai, C. Y.

AU - Chung, I. H.

AU - Chen, W. J.

AU - Lin, K. H.

PY - 2012/11

Y1 - 2012/11

N2 - Although accumulating evidence has confirmed the important roles of thyroid hormone (T 3) and its receptors (TRs) in tumor progression, the specific functions of TRs in carcinogenesis remain unclear. In the present study, tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) was directly upregulated by T 3 in TR-overexpressing hepatoma cell lines. TRAIL is an apoptotic inducer, but it can nonetheless trigger non-apoptotic signals favoring tumorigenesis in apoptosis-resistant cancer cells. We found that TR-overexpressing hepatoma cells treated with T 3 were apoptosis resistant, even when TRAIL was upregulated. This apoptotic resistance may be attributable to simultaneous upregulation of Bcl-xL by T 3, because (1) knockdown of T 3-induced Bcl-xL expression suppressed T 3-mediated protection against apoptosis, and (2) overexpression of Bcl-xL further protected hepatoma cells from TRAIL-induced apoptotic death, consequently leading to TRAIL-promoted metastasis of hepatoma cells. Moreover, T 3-enhanced metastasis in vivo was repressed by the treatment of TRAIL-blocking antibody. Notably, TRAIL was highly expressed in a subset of hepatocellular carcinoma (HCC) patients, and this high-level expression was significantly correlated with that of TRs in these HCC tissues. Together, our findings provide evidence for the existence of a novel mechanistic link between increased TR and TRAIL levels in HCC. Thus, TRs induce TRAIL expression, and TRAIL thus synthesized acts in concert with simultaneously synthesized Bcl-xL to promote metastasis, but not apoptosis.

AB - Although accumulating evidence has confirmed the important roles of thyroid hormone (T 3) and its receptors (TRs) in tumor progression, the specific functions of TRs in carcinogenesis remain unclear. In the present study, tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) was directly upregulated by T 3 in TR-overexpressing hepatoma cell lines. TRAIL is an apoptotic inducer, but it can nonetheless trigger non-apoptotic signals favoring tumorigenesis in apoptosis-resistant cancer cells. We found that TR-overexpressing hepatoma cells treated with T 3 were apoptosis resistant, even when TRAIL was upregulated. This apoptotic resistance may be attributable to simultaneous upregulation of Bcl-xL by T 3, because (1) knockdown of T 3-induced Bcl-xL expression suppressed T 3-mediated protection against apoptosis, and (2) overexpression of Bcl-xL further protected hepatoma cells from TRAIL-induced apoptotic death, consequently leading to TRAIL-promoted metastasis of hepatoma cells. Moreover, T 3-enhanced metastasis in vivo was repressed by the treatment of TRAIL-blocking antibody. Notably, TRAIL was highly expressed in a subset of hepatocellular carcinoma (HCC) patients, and this high-level expression was significantly correlated with that of TRs in these HCC tissues. Together, our findings provide evidence for the existence of a novel mechanistic link between increased TR and TRAIL levels in HCC. Thus, TRs induce TRAIL expression, and TRAIL thus synthesized acts in concert with simultaneously synthesized Bcl-xL to promote metastasis, but not apoptosis.

KW - apoptosis

KW - metastasis

KW - thyroid hormone receptor

KW - TRAIL

UR - http://www.scopus.com/inward/record.url?scp=84870974529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870974529&partnerID=8YFLogxK

U2 - 10.1038/cdd.2012.58

DO - 10.1038/cdd.2012.58

M3 - Article

C2 - 22576662

AN - SCOPUS:84870974529

VL - 19

SP - 1802

EP - 1814

JO - Cell Death and Differentiation

JF - Cell Death and Differentiation

SN - 1350-9047

IS - 11

ER -